Cargando…
Fuzi Enhances Anti-Tumor Efficacy of Radiotherapy on Lung Cancer
In traditional Chinese medicine, Fuzi is widely used as an antitumor agent or an adjuvant medication combined with radiotherapy and chemotherapy, but its mechanism remains unclear. In this study, we investigated anti-tumor and immunoregulation efficacy of Fuzi combined with radiotherapy in mice with...
Autores principales: | Zhang, Qi, Chen, Xue, Luo, Youjun, Ren, Huaping, Qiao, Tiankui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705996/ https://www.ncbi.nlm.nih.gov/pubmed/29187869 http://dx.doi.org/10.7150/jca.22162 |
Ejemplares similares
-
Analgecine enhances the anti-tumor response of radiotherapy by increasing apoptosis and cell cycle arrest in non-small cell lung cancer
por: Chen, Xue, et al.
Publicado: (2017) -
Antitumor effects of nadroparin combined with radiotherapy in Lewis lung cancer models
por: Zhuang, Xibing, et al.
Publicado: (2018) -
os fuzis
Publicado: (1990) -
High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells
por: Chen, Xue, et al.
Publicado: (2016) -
Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo
por: Luo, Lumeng, et al.
Publicado: (2019)